|ITCI -- USA Stock|| |
USD 20.80 0.17 0.82%
Dr. Lawrence P. Wennogle Ph.D. is Vice President Drug Discovery of IntraCellular Therapies Inc. For the past 33 years Dr. Wennogle was involved in research and development in the pharmaceutical industry aimed at the discovery of novel pharmaceutical entities for human diseases. He was a Staff Scientist and Principal Research Fellow at CibaGeigy and Novartis Pharmaceutical Corporationrationration for 19 years where he led drug discovery programs for CNS disorders cardiovascular diseases diabetes and inflammation
Age: 65 President Since 2014 Ph.D
Wennogle received his B.A. from Ithaca College and his Ph.D. in Biochemistry from the University of Colorado, Boulder. He then completed two postdoctoral positions, one at the University of Colorado and the second at the Pasteur Institute in Paris, France, working under JeanPierre Changeux on the structurefunction of the nicotinic acetylcholine receptor.